vs
自然阳光（NATR）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是自然阳光的1.8倍（$217.4M vs $123.8M），自然阳光净利率更高（3.3% vs 1.4%，领先1.9%），自然阳光同比增速更快（4.7% vs 0.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $7.6M），过去两年自然阳光的营收复合增速更高（5.6% vs 3.0%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
NATR vs RPD — 直观对比
营收规模更大
RPD
是对方的1.8倍
$123.8M
营收增速更快
NATR
高出4.2%
0.5%
净利率更高
NATR
高出1.9%
1.4%
自由现金流更多
RPD
多$28.9M
$7.6M
两年增速更快
NATR
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $217.4M |
| 净利润 | $4.1M | $3.1M |
| 毛利率 | 72.5% | 68.9% |
| 营业利润率 | 4.3% | 1.0% |
| 净利率 | 3.3% | 1.4% |
| 营收同比 | 4.7% | 0.5% |
| 净利润同比 | 1379.4% | 44.1% |
| 每股收益（稀释后） | $0.23 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRRPD
| Q4 25 | $123.8M | $217.4M | ||
| Q3 25 | $128.3M | $218.0M | ||
| Q2 25 | $114.8M | $214.2M | ||
| Q1 25 | $113.2M | $210.3M | ||
| Q4 24 | $118.2M | $216.3M | ||
| Q3 24 | $114.6M | $214.7M | ||
| Q2 24 | $110.6M | $208.0M | ||
| Q1 24 | $111.0M | $205.1M |
净利润NATRRPD
| Q4 25 | $4.1M | $3.1M | ||
| Q3 25 | $5.3M | $9.8M | ||
| Q2 25 | $5.3M | $8.3M | ||
| Q1 25 | $4.7M | $2.1M | ||
| Q4 24 | $-321.0K | $2.2M | ||
| Q3 24 | $4.3M | $15.4M | ||
| Q2 24 | $1.3M | $6.5M | ||
| Q1 24 | $2.3M | $1.4M |
毛利率NATRRPD
| Q4 25 | 72.5% | 68.9% | ||
| Q3 25 | 73.3% | 70.2% | ||
| Q2 25 | 71.7% | 70.6% | ||
| Q1 25 | 72.1% | 71.7% | ||
| Q4 24 | 72.0% | 69.5% | ||
| Q3 24 | 71.3% | 70.6% | ||
| Q2 24 | 71.4% | 70.7% | ||
| Q1 24 | 71.2% | 70.3% |
营业利润率NATRRPD
| Q4 25 | 4.3% | 1.0% | ||
| Q3 25 | 7.0% | 2.7% | ||
| Q2 25 | 3.7% | 1.6% | ||
| Q1 25 | 5.4% | -0.0% | ||
| Q4 24 | 3.8% | 3.4% | ||
| Q3 24 | 4.6% | 6.0% | ||
| Q2 24 | 5.1% | 2.5% | ||
| Q1 24 | 4.2% | 4.7% |
净利率NATRRPD
| Q4 25 | 3.3% | 1.4% | ||
| Q3 25 | 4.2% | 4.5% | ||
| Q2 25 | 4.6% | 3.9% | ||
| Q1 25 | 4.2% | 1.0% | ||
| Q4 24 | -0.3% | 1.0% | ||
| Q3 24 | 3.8% | 7.2% | ||
| Q2 24 | 1.2% | 3.1% | ||
| Q1 24 | 2.1% | 0.7% |
每股收益（稀释后）NATRRPD
| Q4 25 | $0.23 | $0.05 | ||
| Q3 25 | $0.30 | $0.15 | ||
| Q2 25 | $0.28 | $0.13 | ||
| Q1 25 | $0.25 | $0.03 | ||
| Q4 24 | $-0.02 | $0.08 | ||
| Q3 24 | $0.23 | $0.21 | ||
| Q2 24 | $0.07 | $0.09 | ||
| Q1 24 | $0.12 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $161.6M | $154.7M |
| 总资产 | $261.1M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NATRRPD
| Q4 25 | $93.9M | $474.7M | ||
| Q3 25 | $95.6M | $407.1M | ||
| Q2 25 | $81.3M | $511.7M | ||
| Q1 25 | $86.5M | $493.5M | ||
| Q4 24 | $84.7M | $521.7M | ||
| Q3 24 | $78.7M | $443.7M | ||
| Q2 24 | $68.7M | $442.6M | ||
| Q1 24 | $77.8M | $411.7M |
总债务NATRRPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
股东权益NATRRPD
| Q4 25 | $161.6M | $154.7M | ||
| Q3 25 | $166.7M | $127.2M | ||
| Q2 25 | $163.7M | $90.4M | ||
| Q1 25 | $167.1M | $52.7M | ||
| Q4 24 | $161.0M | $17.7M | ||
| Q3 24 | $162.6M | $-5.1M | ||
| Q2 24 | $156.4M | $-52.6M | ||
| Q1 24 | $159.7M | $-86.4M |
总资产NATRRPD
| Q4 25 | $261.1M | $1.7B | ||
| Q3 25 | $264.8M | $1.7B | ||
| Q2 25 | $254.9M | $1.6B | ||
| Q1 25 | $252.7M | $1.6B | ||
| Q4 24 | $240.9M | $1.7B | ||
| Q3 24 | $245.3M | $1.6B | ||
| Q2 24 | $235.8M | $1.5B | ||
| Q1 24 | $247.3M | $1.5B |
负债/权益比NATRRPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $36.4M |
| 自由现金流率自由现金流/营收 | 6.1% | 16.8% |
| 资本支出强度资本支出/营收 | 1.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.41× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $28.8M | $146.2M |
8季度趋势，按日历期对齐
经营现金流NATRRPD
| Q4 25 | $9.9M | $37.6M | ||
| Q3 25 | $18.5M | $39.0M | ||
| Q2 25 | $4.3M | $47.5M | ||
| Q1 25 | $2.6M | $29.8M | ||
| Q4 24 | $12.2M | $63.8M | ||
| Q3 24 | $9.6M | $44.0M | ||
| Q2 24 | $1.3M | $32.9M | ||
| Q1 24 | $2.2M | $31.1M |
自由现金流NATRRPD
| Q4 25 | $7.6M | $36.4M | ||
| Q3 25 | $16.8M | $34.8M | ||
| Q2 25 | $3.0M | $46.6M | ||
| Q1 25 | $1.5M | $28.4M | ||
| Q4 24 | $10.0M | $62.6M | ||
| Q3 24 | $7.9M | $42.6M | ||
| Q2 24 | $-2.0M | $32.6M | ||
| Q1 24 | $-1.5M | $30.4M |
自由现金流率NATRRPD
| Q4 25 | 6.1% | 16.8% | ||
| Q3 25 | 13.1% | 16.0% | ||
| Q2 25 | 2.6% | 21.8% | ||
| Q1 25 | 1.3% | 13.5% | ||
| Q4 24 | 8.5% | 28.9% | ||
| Q3 24 | 6.9% | 19.9% | ||
| Q2 24 | -1.9% | 15.7% | ||
| Q1 24 | -1.4% | 14.8% |
资本支出强度NATRRPD
| Q4 25 | 1.9% | 0.5% | ||
| Q3 25 | 1.3% | 1.9% | ||
| Q2 25 | 1.2% | 0.4% | ||
| Q1 25 | 1.0% | 0.6% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.5% | 0.6% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 0.3% |
现金转化率NATRRPD
| Q4 25 | 2.41× | 12.01× | ||
| Q3 25 | 3.46× | 3.97× | ||
| Q2 25 | 0.81× | 5.70× | ||
| Q1 25 | 0.55× | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | 2.21× | 2.85× | ||
| Q2 24 | 0.97× | 5.03× | ||
| Q1 24 | 0.94× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
